On Wednesday shares of United States Steel Corp. (NYSE:X) closed at $23.67. Company’s sales growth for last 5 years was 9.60% and EPS growth for next 5 years is recorded as -3.93%. Barclays set a $24.00 price target on shares of United States Steel (NYSE:X) stock in a research note issued on Tuesday. The firm currently has a “hold” rating on the stock.
On Wednesday shares of General Motors Company (NYSE:GM) closed at $35.51. Company’s sales growth for last 5 years was 8.30% and EPS growth for next 5 years is recorded as 18.16%. General Motors Co. (NYSE:GM) plans to announce on Thursday that it will invest several billion dollars on its North American manufacturing plants over multiple years, according to report citing people familiar with the matter.
Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity decreased -0.39% to close at $64.29. Company weekly performance is -3.47% while its quarterly performance stands at 5.43%. Bristol-Myers Squibb Company (NYSE:BMY) is -6.56% away from its 52 week high. Bristol-Myers Squibb Company (NYSE:BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for the treatment of previously untreated patients with unresectable or metastatic melanoma. The FDA also granted Priority Review for this application. The projected FDA action date is August 27, 2015.
On last trading day Rayonier Inc. (NYSE:RYN) fell -0.46% to close at $25.85. Its volatility for the week is 1.04% while volatility for the month is 1.25%. RYN’s sales growth for past 5 years was -12.40% and its EPS growth for past 5 years was -30.20%. Rayonier Inc. (NYSE:RYN) monthly performance is -4.01%. Rayonier Inc. (NYSE:RYN) plans to release its first quarter 2015 earnings on Wednesday, May 6, 2015, after the market closes.
ANN INC. (NYSE:ANN) has 2.10% insider ownership while its institutional ownership stands at 92.40%. In last trading activity company’s stock closed at $37.61. On April 27, ANN INC. (NYSE:ANN), donated more than $4.3 million to the Breast Cancer Research Foundation® (BCRF) to fund groundbreaking cancer research from the success of the brand’s 2014 spring and fall campaigns, bringing the Company’s total corporate donation to $22.3 million in the past 10 years.